Cargando…

MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis

Circulating microRNAs (miRNAs) can be employed as biomarkers to diagnose liver and other diseases. Noninvasive approaches are needed to complement and improve the current strategies for screening for biomarkers liver cirrhosis. We determined whether the serum levels of miRNAs can distinguish between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hui, Yan, Xiu-Li, Guo, Xin-Xin, Shi, Miao-Juan, Lu, Yi-Yu, Zhou, Qian-Mei, Chen, Qi-Long, Hu, Yi-Yang, Xu, Lie-Ming, Huang, Shuang, Su, Shi-Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787420/ https://www.ncbi.nlm.nih.gov/pubmed/29416678 http://dx.doi.org/10.18632/oncotarget.23262

Ejemplares similares

The miR-23b/27b/24-1 Cluster Inhibits Hepatic Fibrosis by Inactivating Hepatic Stellate Cells
por: Wan, Lin-Yan, et al.
Publicado: (2022)

Glycyrrhetinic Acid-Induced MiR-663a Alleviates Hepatic Stellate Cell Activation by Attenuating the TGF-β/Smad Signaling Pathway
por: Guo, Xin-Xin, et al.
Publicado: (2020)

Suppression of hepatic stellate cell activation through downregulation of gremlin1 expression by the miR-23b/27b cluster
por: Zeng, Xian-Yi, et al.
Publicado: (2016)

Role of triglycerides as a predictor of autoimmune hepatitis with cirrhosis
por: Wang, Peng, et al.
Publicado: (2022)

Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B
por: Zhang, Hui, et al.
Publicado: (2013)

Hepatocyte-derived exosomal miR-27a activateshepatic stellate cells through the inhibitionof PINK1-mediated mitophagy in MAFLD
por: Luo, Xin, et al.
Publicado: (2021)

Effect of TGF-β/smad signaling pathway blocking on expression profiles of miR-335, miR-150, miR-194, miR-27a, and miR-199a of hepatic stellate cells (HSCs)
por: Davoodian, Parivash, et al.
Publicado: (2017)

Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells
por: Chen, Xiaogang, et al.
Publicado: (2020)

Neuroimmunomodulation of adrenoblockers during liver cirrhosis: modulation of hepatic stellate cell activity
por: Medina Pizaño, Mariana Yazmin, et al.
Publicado: (2023)

MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression
por: Li, Binbin, et al.
Publicado: (2021)

Functional Study of miR-27a in Human Hepatic Stellate Cells by Proteomic Analysis: Comprehensive View and a Role in Myogenic Tans-Differentiation
por: Ji, Yuhua, et al.
Publicado: (2014)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
por: Zhou, Li, et al.
Publicado: (2017)

miR‐193a/b‐3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells
por: Ju, Baoling, et al.
Publicado: (2019)

Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
por: Lang, Zhichao, et al.
Publicado: (2023)

Identification of miRNAs associated with the mechanical response of hepatic stellate cells by miRNA microarray analysis
por: Yi, Suhong, et al.
Publicado: (2018)

LOC102553417 silencing facilitates the apoptosis of hepatic stellate cells via the miR-30e/MTDH axis
por: Wei, Wujun, et al.
Publicado: (2022)

Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease
por: Luo, Xin, et al.
Publicado: (2021)

Correction: Functional Study of miR-27a in Human Hepatic Stellate Cells by Proteomic Analysis: Comprehensive View and a Role in Myogenic Tans-Differentiation
Publicado: (2015)

miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
por: Wei, Song, et al.
Publicado: (2019)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015)

Predictors of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
por: Sharma, Praveen, et al.
Publicado: (2010)

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
por: Qiu, Jiannan, et al.
Publicado: (2022)

MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway
por: Zhang, Jie, et al.
Publicado: (2021)

miR-7-5p Promotes Hepatic Stellate Cell Activation by Targeting Fibroblast Growth Factor Receptor 4
por: Tian, Shuxia, et al.
Publicado: (2020)

Galangin delivered by retinoic acid-modified nanoparticles targeted hepatic stellate cells for the treatment of hepatic fibrosis
por: Xiong, Yuanguo, et al.
Publicado: (2023)

Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway
por: Song, Li-Ying, et al.
Publicado: (2019)

Hepatic Stellate Cells and Hepatocarcinogenesis
por: Barry, Anna E., et al.
Publicado: (2020)

Study of ZHENG differentiation in Hepatitis B-caused cirrhosis: a transcriptional profiling analysis
por: Lu, Yi-Yu, et al.
Publicado: (2014)

Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis
por: El-Ahwany, Eman, et al.
Publicado: (2016)

miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRα
por: Ma, Heming, et al.
Publicado: (2022)

Dihydroartemisinin inhibits the activation and proliferation of hepatic stellate cells by regulating miR-29b-3p
por: Huan, Sheng, et al.
Publicado: (2023)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis
por: Liu, Boqiang, et al.
Publicado: (2022)

Hepatic stellate cells: central modulators of hepatic carcinogenesis
por: Thompson, Alexandra I, et al.
Publicado: (2015)

Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis
por: Wang, Zhijun, et al.
Publicado: (2012)

Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation
por: Shi, Chun-xia, et al.
Publicado: (2021)

Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma
por: Elghoroury, Eman A, et al.
Publicado: (2022)

Interleukin-10 Genotype Correlated to Deficiency Syndrome in Hepatitis B Cirrhosis
por: Li, Qing-Ya, et al.
Publicado: (2012)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1takr9o4jfnptc59c7s026qv5